Evidence map›Paper›PMID 29251792›Full record

ArticleHepatology (Baltimore, Md.)2018

Extracellular vesicles from mice with alcoholic liver disease carry a distinct protein cargo and induce macrophage activation through heat shock protein 90.

Banishree Saha, Fatemeh Momen-Heravi, Istvan Furi, Karen Kodys, Donna Catalano, Anwesha Gangopadhyay, Reka Haraszti, Abhishek Satishchandran, Arvin Iracheta-Vellve, Adeyinka Adejumo and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Hepatology (Baltimore, Md.), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 85 papers.

0numbers the graph read from it
0cells of the map it votes in
85citing papers in PubMed
6.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

85 citing papers in PubMed, 124 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Review
  20. Review

25 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Banishree SahaDepartment of Medicine, University of Massachusetts Medical School, Worcester, MA.
Fatemeh Momen-HeraviDepartment of Medicine, University of Massachusetts Medical School, Worcester, MA.
Istvan FuriDepartment of Medicine, University of Massachusetts Medical School, Worcester, MA.
Karen KodysDepartment of Medicine, University of Massachusetts Medical School, Worcester, MA.
Donna CatalanoDepartment of Medicine, University of Massachusetts Medical School, Worcester, MA.
Anwesha GangopadhyayDepartment of Medicine, University of Massachusetts Medical School, Worcester, MA.
Reka HarasztiRNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA.
Abhishek SatishchandranDepartment of Medicine, University of Massachusetts Medical School, Worcester, MA.
Arvin Iracheta-VellveDepartment of Medicine, University of Massachusetts Medical School, Worcester, MA.
Adeyinka AdejumoDepartment of Medicine, University of Massachusetts Medical School, Worcester, MA.
Scott A ShafferProteomics and Mass Spectrometry Facility and Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, MA.
Gyongyi SzaboDepartment of Medicine, University of Massachusetts Medical School, Worcester, MA.
University of Massachusetts Chan Medical School · USColumbia University · US

Funding

Alcohol and Monocyte Signaling Administrative SupplementR01AA011576 · NIAAA · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI Gyongyi Szabo · 1998 to 2026
$9.3M
Novel Therapies for Alcoholic HepatitisU01AA021893 · NIAAA · CLEVELAND CLINIC LERNER COM-CWRU · PI MCCLAIN, CRAIG J., MCCULLOUGH, ARTHUR JOSEPH · 2012 to 2017
$6.0M
Novel Therapies in alcoholic hepatitis - UMMS Translational ProgramU01AA021907 · NIAAA · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI SZABO, GYONGYI · 2012 to 2017
$2.0M
The Role of miR-122 in Alcoholic Liver DiseaseF30AA022283 · NIAAA · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI SATISHCHANDRAN, ABHISHEK · 2013 to 2017
$155k
STING and IRF3 activation by cyclic dinucleotides in early alcoholic liver diseaseF31AA025545 · NIAAA · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI IRACHETA-VELLVE, ARVIN · 2016 to 2017
$39k
NIAAA NIH HHS F30 AA022283NIAAA NIH HHS F31 AA025545NIAAA NIH HHS R01 AA011576NIAAA NIH HHS U01 AA021893NIAAA NIH HHS U01 AA021907
6 · The paper itself

Abstract

A salient feature of alcoholic liver disease (ALD) is Kupffer cell (KC) activation and recruitment of inflammatory monocytes and macrophages (MØs). These key cellular events of ALD pathogenesis may be mediated by extracellular vesicles (EVs). EVs transfer biomaterials, including proteins and microRNAs, and have recently emerged as important effectors of intercellular communication. We hypothesized that circulating EVs from mice with ALD have a protein cargo characteristic of the disease and mediate biological effects by activating immune cells. The total number of circulating EVs was increased in mice with ALD compared to pair-fed controls. Mass spectrometric analysis of circulating EVs revealed a distinct signature for proteins involved in inflammatory responses, cellular development, and cellular movement between ALD EVs and control EVs. We also identified uniquely important proteins in ALD EVs that were not present in control EVs. When ALD EVs were injected intravenously into alcohol-naive mice, we found evidence of uptake of ALD EVs in recipient livers in hepatocytes and MØs. Hepatocytes isolated from mice after transfer of ALD EVs, but not control EVs, showed increased monocyte chemoattractant protein 1 mRNA and protein expression, suggesting a biological effect of ALD EVs. Compared to control EV recipient mice, ALD EV recipient mice had increased numbers of F4/80

conclusionOur study indicates a specific protein signature of ALD EVs and demonstrates a functional role of circulating EVs containing heat shock protein 90 in mediating KC/MØ activation in the liver. (Hepatology 2018;67:1986-2000).

Indexed as

AnimalsCytokinesExtracellular VesiclesFemaleHepatocytesHSP90 Heat-Shock ProteinsLiverLiver Diseases, AlcoholicMacrophage ActivationMacrophagesMaleMass SpectrometryMiceMice, Inbred C57BLCytokinesHSP90 Heat-Shock Proteins

Identifiers

PMID29251792
PMCPMC5906190
OpenAlexW2799991971

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.